Referințe

1.           National Cancer Institute, Tumor Markers, https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet#q1. Data accesării: 20 martie 2018

2.           Ghidul ESMO pentru pacienți, Ce este cancerul de plămân fără celule mici?, https://www.esmo.org/content/download/303704/6040931/1/RO-Cancerul-de-Plaman-Fara-Celule-Mici-Ghidul-pentru-Pacienti.pdf

3.           Bücheler M. et al. Personalised Medicine, in Europe- Enhancing Patient Access to Pharmaceutical Drug-Diagnostic Companion Products, Patient Access Study Nov. 2014. EPEMED White Paper, Charite, Berlin

4.           Strimbu et al. What are Biomarkers? Curr Opin HIV AIDS 2010;5:463-466

5.           Institutul Oncologic “Prof. Dr. Ioan Chiricuță”, Cancerul Pulmonar http://www.iocn.ro/Document_Files/Ghiduri-%C5%9Fi Bro%C5%9Furi/00000772/0opmf_Cancerul%20Pulmonar.pdf

6.           Lung Cancer Alliance, http://www.lungcanceralliance.org/get-information/types-of-lung-cancer.html

7.           Bray et all., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries; CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492

8.           The Global Cancer Observatory, ianuarie 2019 – http://gco.iarc.fr/today/data/factsheets/populations/642-romania-fact-sheets.pdf

9.           Lung cancer alliance, Symptoms of lung cancer: https://lungcanceralliance.org/what-is-lung-cancer/symptoms/

10.         American Cancer Society. Small Cell Lung Cancer Risk Factors. Available at: https://www.cancer.org/cancer/small-cell-lung-cancer/causes-risks-prevention/risk-factors.html

11.         Institutul de Pneumoftiziologie “Marius Nasta”, Ghidul Pacientului – Cancer Pulmonar, https://marius-nasta.ro/ghidul-pacientului/cancerul-pulmonar/

12.         The International Association for the Study of Lung Cancer Asociația internațională de studiu al cancerului, https://www.iaslc.org

13. https://www.macmillan.org.uk/_images/Lung_cancer_combined_ROMANIAN_tcm9-343401.pdf

14.         Carta Albă a Imuno-Oncologiei, InoMed 2018

15.         Societatea Română de Pneumologie, Ghid pentru Managementul Cancerului Pulmonar, https://www.srp.ro/ghiduri/Ghid%20pentru%20managementul%20cancerului%20pulmonar%20-%20Partea%20a%20II-a%20-%20Tratament.pdf

16.         http://www.icfundeni.ro/gpn2/wp/wp-content/uploads/2014/10/GPN2-RF-RStiintific1.pdf

17.         Cancer Research Institute. What is Cancer Immunotherapy? – http://www.cancerresearch.org/cancer-immunotherapy/what-is- cancer-immunotherapy

18.         ACS, Radiation Therapy – What it is, How it helps: https://www.cancer.org/content/dam/cancer-org/cancer-control/en/booklets-flyers/radiation-therapy-what-it-is-how-it-helps.pdf

19.         https://oncopedia.ro/modalitati-terapeutice/terapiile-tintite/

20.         Societatea Română de Pneumologie,  https://www.srp.ro/Pacienti/cancerulpulmonar.aspx

21.         Vargas et al. Biomarker development in the precision medicine era: lung cancer as a case study. Nature Reviews Cancer 2016;16:525-537

22.         Hofman, Paul. “ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.” Cancers vol. 9,8 107. 12 Aug. 2017, doi:10.3390/cancers9080107, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575610/

23.         DAKO: PD-L1 IHC 22C3 pharmDx product information (http://www.agilent.com/en/products/pharmdx/pd-l1- ihc-22c3-pharmdx?set-Country=true&purl=ar39/, accessed on 20/12/2016)